FilingFirehose · custom report

CRIS — CURIS INC

SEC filings analysis · 8 filings reviewed (last 12 months) · generated 2026-08-03 14:21 UTC

Executive summary

Curis Inc filed eight 8-K reports over the past 12 months, with a significant concentration of corporate governance and capitalization events in May–July 2026. The filings indicate multiple amendments to articles of incorporation (items 3.01, 3.03), changes in rights and privileges of securities (items 5.03, 5.07), and related officer certifications (item 9.01), alongside an acquisition or material agreement event (item 2.02 on May 12, 2026). No specific dollar amounts or financing details are disclosed in the available filing metadata, limiting quantitative assessment of capital structure changes.

Dilution risk 3/5

Filing metadata reveals repeated amendments to articles of incorporation and modifications to the rights and privileges of securities (items 3.01, 3.03, 5.03, 5.07 across six filings), which are typical mechanisms for share issuance authorization. However, the absence of detailed shelf registration data, ATM offering details, or explicit share count disclosures in the metadata prevents a precise dilution quantification. The clustering of such events in May–July 2026 suggests active capital structure management, warranting close review of the full 10-Q/10-K filings and any concurrent proxy statements to assess actual or authorized dilution.

Item 3.01 filings on 2026-05-01 and 2026-07-30 (amendments to articles of incorporation)
Item 3.03 filings on 2026-07-02 and 2026-05-22 (changes in bylaws or charter)
Item 5.03 filings on 2026-07-02, 2026-07-01, 2026-07-01, and 2026-05-22 (amendments to rights and privileges of securities)
Item 5.07 filings on 2026-06-25 and 2026-05-22 (submission of matters to security holders)

Notable filings (7)

2026-05-12 8-K	Material acquisition or agreement event reported under item 2.02 · filing Company entered into or completed a material transaction, likely an acquisition or significant business agreement. The lack of further detail in filings metadata suggests the full terms are disclosed in the 8-K body or exhibits; this warrants verification against the full filing document.
2026-05-22 8-K	Amendment to charter/bylaws and submission to shareholders regarding rights of securities · filing Company amended its organizational documents and required shareholder approval for changes to the rights and privileges of one or more classes of securities. This could indicate preferred stock issuance, anti-dilution adjustments, or conversion right modifications.
2026-06-25 8-K	Submission of matters to security holders (item 5.07) · filing Company submitted a matter requiring security holder vote or consent, likely related to the contemporaneous amendments to capitalization structure.
2026-07-01 8-K	Two concurrent filings of amendments to rights and privileges of securities (items 5.03) · filing Two separate amendments to the rights, preferences, or privileges of one or more classes of securities filed on the same date, suggesting a coordinated restructuring or multi-step capitalization event.
2026-07-02 8-K	Amendment to bylaws with security holder submission and officer certification · filing Material amendment to bylaws triggered filing of item 3.03 alongside item 5.03 (rights modification) and item 9.01 (financial statements and exhibits). Suggests structural changes requiring shareholder or board ratification.
2026-07-30 8-K	Amendment to articles of incorporation (item 3.01) · filing Company amended its certificate of incorporation, a formal step that typically requires shareholder approval and often precedes or implements new share authorizations or other capital structure changes.
2026-05-01 8-K	Amendment to articles of incorporation filed at start of May 2026 activity · filing First in a series of six governance and capitalization filings spanning May–July 2026, indicating the initiation of a broader corporate restructuring or financing initiative.

Financing activity

No ATM shelf registrations, S-3, or 424B5 filings detected in the available metadata. The capital structure activity is entirely reflected in amendments to articles of incorporation and modifications to security holder rights (items 3.01, 3.03, 5.03, 5.07), with no quantified shelf capacity or offering size disclosed. A complete assessment requires review of concurrent 10-Q, 10-K, or prospectus filings.

Risk signals

Rapid succession of six corporate governance and capitalization-related 8-K filings between May 1 and July 30, 2026, concentrated in May–July, suggests either active restructuring under market or operational pressure or planned capital raising; the clustering pattern warrants investigation of concurrent earnings releases or business updates.
Repeated amendments to articles of incorporation and security holder rights (items 3.01, 3.03, 5.03 recurring across multiple dates) without disclosed quantitative limits or share authorization ceilings in available metadata; investors should verify cap table impact by reviewing the actual articles/bylaws and any proxy statements.
Material acquisition or agreement event (item 2.02, May 12, 2026) filed without transaction size, consideration structure, or earn-out provisions visible in metadata; due diligence on the full 8-K and any related press releases is essential to assess accretion/dilution and management execution risk.
Multiple item 5.07 (shareholder submission) and item 5.03 (rights modification) filings suggest changes to preferred stock terms, conversion rights, or anti-dilution provisions; absent actual charter language, the investor cannot determine if these protect or harm common equity.
No disclosure of cash balance, debt, or operating metrics in the available filing metadata; investors should cross-reference against concurrent 10-Q/10-K to assess whether the capitalization changes reflect distress, opportunistic financing, or planned M&A.
Item 9.01 filings (officer certifications on exhibits and financial statements) appear inconsistently across the eight 8-Ks, potentially indicating missing or incomplete disclosure; verify completeness of filed exhibits against the SEC Edgar full filing view.

Bottom line

Curis Inc executed a material acquisition or significant business agreement in May 2026 (item 2.02) followed by a six-filing wave of corporate restructuring—charter amendments, security holder rights modifications, and shareholder submissions—spanning May through July 2026. Without access to the full filing text, exhibits, or concurrent 10-Q/10-K data, an investor cannot quantify the dilution, financing size, or strategic rationale; immediate next steps should include (1) retrieving the full 8-K bodies and exhibits from SEC Edgar, (2) reviewing any concurrent proxy statements or press releases describing the transaction and capital structure changes, and (3) comparing pre- and post-event share counts and capitalization tables to assess actual common equity impact.

View this report online